Screen2Prevent (S2P)

Recruiting now · Not applicable

Conditions studied: HIV Infections

In brief

Screen2Prevent is a study intended to improve HIV prevention and detection through implementation and evaluation of three different broad-scale HIV screening approaches a) targeted, b) universally offered opt-in, and c) universally offered opt-out in Emergency Departments (EDs) by leveraging digital health to identify and link adolescents seeking care in the ED to HIV Pre-Exposure Prophylaxis (PrEP)/Antiretroviral treatment (ART).

Key facts

Study ID

NCT07728123

Run by

Westat

People needed

84000

Starts

2026-06-16

Expected to finish

2028-10-31

Last updated by the study team

2026-07-27

Who can join

Age: 14 and older, up to 24. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age 14-24 years, inclusive
• Present to the participating ED, regardless of chief complaint during the study period

You may not qualify if…

• None

Where it is running

• University of South Florida — Tampa, Florida, United States (enrolling)
• St. Jude Children's Research Hospital — Memphis, Tennessee, United States (enrolling)
• Emory Atlanta Adolescent Consortium — Atlanta, Georgia, United States
• Johns Hopkins University — Baltimore, Maryland, United States
• Baylor College of Medicine — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.